The relationship between the hypothalamo-pituitary-gonadal (HPG) axis and the hypothalamo-pituitary-adrenal (HPA) axis has been well documented in the rat. In most cases, a negative coupling was observed and an inhibitory effect of the HPA axis upon the HPG was shown. In the female rat, a marked circadian rhythm of corticosterone plasma values is observed during each day of the estrous cycle, with maximal values around 08:00 p.m. The preovulatory luteinizing hormone (LH) surge also occurs at 08:00 p.m. on the day of proestrus. Here we measured circadian variations of plasma cortisol in humans in relation with the time of initiation of the preovulatory LH surge. Blood samples were taken at 08:00 a.m., 12:00 a.m., 04:00 p.m., 08:00 p.m., 12:00 p.m., and 04:00 a.m. from 19 subjects for 4 consecutive days, once 17β-estradiol (E2) values reached 125 pg/ml (days 7–10 of the menstrual cycle). Serum E2 and LH determinations were performed by microparticle enzyme immunoassays. Serum progesterone and plasma cortisol determinations were made using RIA methods. For plasma cortisol values, a marked circadian rhythm, with 2- to 3-fold higher values during the morning than during the afternoon, was almost identical before, during and after the LH surge. However, values were generally higher during the follicular phase than during the luteal phase. Maximum cortisol values occurred between 04:00 and 08:00 a.m. and minimal cortisol values between 04:00 and 08:00 p.m. Initiation of the LH surge (50% over the mean of previous values) occurred at 04:00 a.m. (20% of the cases) or at 08:00 a.m. (80% of the cases). There was a strong coupling between the onset of the surge and the acrophase of the cortisol circadian rhythm: maximal cortisol plasma values were seen at 04:00 a.m. when the LH preovulatory surge started at 04:00 a.m. and 08:00 a.m. when it started at 08:00 a.m. The present results show that the positive coupling documented in the female rat between the HPA and the HPG axis at the time of preovulatory LH surge is also present during the menstrual cycle in the human.

Keywords:
Menstrual cycle, Gonadal steroids, Adrenal steroids, Gonadotropins, Circadian rhythms, Clinical neuroendocrinology
1.
Selye H: Effects of adaptation to various damaging agents on the female sex organs in the rat. Endocrinology 1939;25:615–624.
2.
Rivier C, Rivier J, Vale W: Stress-induced inhibition of reproductive functions: Role of endogenous corticotropin-releasing factor. Science 1986;231:607–609.
3.
Rivier C, Rivest S: Effect of stress on the activity of hypothalamic-pituitary gonadal axis: Peripheral and central mechanisms. Biol Reprod 1991;45:523–529.
4.
Genazzani AR, Nappi RE, Bencini S, Sgherzi MR, Guo AL, Criscuolo M, et al: Immunoneuroendocrine function and reproduction; in Genazzani AR, Petraglia F, Genazzani AD (eds): Frontiers in Gynecologic and Obstetric Investigation. New York, NY, The Parthenon Publ. Group, 1993.
5.
Hayashi KT, Moberg GP: Influence of the hypothalamic-pituitary-adrenal axis on the menstrual cycle and the pituitary responsiveness to estradiol in the female rhesus monkey (Macaca mulatta). Biol Reprod 1990;42:260–265.
6.
Brann DW, Putnam CD, Mahesh VB: Corticosteroid regulation of gonadotropin secretion and prolactin secretion in the rat. Endocrinology 1990;126:159–166.
7.
Puder JJ, Freda PU, Goland RS, Ferin M, Wardlaw SL: Stimulatory effects of stress on gonadotropin secretion in estrogen-treated women. J Clin Endocrinol Metab 2000;85:2184.
8.
Critchlow V, Liebelt A, Bar-Sela M, Mountcastle W, Lipscomb HS: Sex differences in resting pituitary-adrenal function in the rat. Am J Physiol 1963;205:807–815.
9.
Smith CJ, Norman RL: Influence of the gonads on cortisol secretion in female rhesus macaques. Endocrinology 1987;121:2192–2198.
10.
Viau V, Meaney MJ: Basal and stress hypothalamic-pituitary-adrenal activity in cycling and ovariectomised-steroid treated rats. Endocrinology 1991;129:2503–2511.
11.
Stewart PM, Penn R, Holder R, Parton A, Ratcliffe JG, London DR: The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome. Clin Endocrinol 1993;38:387–391.
12.
Swanson LW, Simmons DM: Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. Comp Neurol 1989;285:413–435.
13.
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH: Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999;61:154–162.
14.
Altemus M, Roca C, Galliven E, Romanos C, Deuster P: Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle. J Clin Endocrinol Metab 2001;86:2525–2530.
15.
Carey WP, Deterd CH, de Koning J, Helmerhorst F, de Kloet ER: The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 1995;144:311–321.
16.
Kerdelhué B, Jones G, Gordon K, Seltman H, Lenoir V, Melik-Parsadaniantz S, et al: Activation of the hypothalamo-anterior pituitary corticotropin-releasing hormone, adrenocorticotropin hormone and β-endorphin systems during the estradiol 17β-induced plasma LH surge in the ovariectomized monkey. J Neurosci Res 1995;42:228–235.
17.
Raps D, Barthe PL, Desaulles PA: Plasma and adrenal corticosterone levels during the different phases of the sexual cycle in normal female rats. Experientia 1971;27:339–340.
18.
Atkinson HC, Waddell BJ: Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: Sexual dimorphism and changes across the estrous cycle. Endocrinology 1997;138:3842–3848.
19.
Naftolin F, Brown-Grant K, Corker CS: Plasma and pituitary luteinizing hormone and peripheral plasma estradiol concentrations in the normal oestrus cycle of the rat and after experimental manipulation of the cycle. Endocrinology 1972;53:17–20.
20.
Chiba A, Akema T, Toyoda J: Effects of pinealectomy and melatonin on the timing of the proestrous luteinizing hormone surge in the rat. Neuroendocrinology 1994;9:163–168.
21.
Lefebvre H, Contess V, Delarue C, Feuilloley M, Hery F, Grise P, Raynaud G, Verhofstad AAJ, Wolf LM, Vaudry H: Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated though activation of a serotonin receptor subtype. Neuroscience 1992;47:999–1007.
22.
Karsch FJ, Weick RF, Butler WR, Dierschke DJ, Krey LC, Weiss G, Hotchkiss J, Yamaji T, Knobil E: Induced LH surges in the rhesus monkey: Strength-duration characteristics of the estrogen stimulus. Endocrinology 1973;92:1740–1747.
23.
Nakai Y, Plant TM, Hess DL, Keogh EJ, Knobil E: On the sites of the negative and positive feedback actions of estradiol in the control of gonadotropin secretion in the rhesus monkey. Endocrinology 1978;102:1008–1014.
24.
Knobil E: The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980;36:53–88.
25.
Kerdelhué B, Jones GS, Gordon K, Seltman H, Lenoir V, Millar RP, William RF, Hodgen GD: Hypothalamo-anterior pituitary gonadotropin-releasing hormone and substance P systems during the 17β-estradiol-induced plasma luteinizing hormone surge in the ovariectomized female monkey. Endocrinology 1993;132:1151–1157.
26.
Kalra SP: Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocr Rev 1993;14:507–538.
27.
Brann DW, Putnam CD, Mahesh VB: Validation of the mechanisms proposed for the stimulatory and inhibitory effects of progesterone on gonadotropin secretion in the estrogen-primed rat: A possible role for adrenal steroids. Steroids 1991;56:103–111.
28.
Hoff JD, Quigley ME, Yen SSC: Hormonal dynamics at midcycle: A re-evaluation. J Clin Endocrinol Metabol 1983;57:792.
29.
Xiao E, Xia-Zhang L, Shanen D, Ferin M: Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol. J Clin Endocrinol Metab 1997;82:571–599.
30.
Williams NI, McArthur JW, Turnbull BA, et al: Effects of follicular phase exercise on luteinizing hormone pulse characteristics in sedentary eumenorrhoeic women. Clin Endocrinol (Oxf) 1994;41:787–794.
31.
Mann DR, Korowitz CD, Barraclough CA: Adrenal gland involvement in synchronizing the preovulatory release of LH in rats. Proc Soc Exp Biol Med 1975;50:115–120.
32.
Brann DW, Mahesh VB: The role of corticosteroids in reproduction. FASEB J 1991;5:2691–2698.
33.
Harlow CR, Jenkins JM, Winston RM: Increased follicular fluid total and free cortisol levels during the luteinizing hormone surge. Fertil Steril 1997;68:48–53.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.